LCID
Lucid Group, Inc.
LCID has the edge over WHR overall, supported by stronger fundamentals and stronger modeled upside.
WHR
Whirlpool Corporation
WHR has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
WHR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
WHR's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
WHR PE Valuation
WHR has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
WHR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect WHR's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over WHR on earnings, with more consistent year-over-year improvement.
WHR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.16 | +$1.21 |
| Q2 2026 | $2.93 | +$5.59 |
| Q1 2026 | $2.95 | +2169% |
| Q4 2025 | $5.66 | +$11.53 |
| Q3 2025 | -$3.37 | -133% |
| Q2 2025 | -$2.66 | -127% |
| Q1 2025 | $0.13 | -98% |
| Q4 2024 | -$5.87 | -167% |
WHR lost $2.16 per share over the past year, a smaller loss than the year before, but its loss has widened in each of the last three quarters.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over WHR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
WHR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | -8.8% |
| Q2 2026 | $3.5B | -6.8% |
| Q1 2026 | $3.3B | -9.6% |
| Q4 2025 | $4.1B | -0.9% |
| Q3 2025 | $4B | +1% |
| Q2 2025 | $3.8B | -5.4% |
| Q1 2025 | $3.6B | -19% |
| Q4 2024 | $4.1B | -19% |
WHR's revenue has slid since its 2021 peak: $3.7B last quarter, down 8.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.1% | -5 points |
| Q2 2026 | 4.6% | -0.8 points |
| Q1 2026 | 0.6% | -4.5 points |
| Q4 2025 | 5.9% | +9.2 points |
| Q3 2025 | 5.1% | -1.5 points |
| Q2 2025 | 5.4% | +2.2 points |
| Q1 2025 | 5.1% | +7.7 points |
| Q4 2024 | -3.3% | -11 points |
WHR has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
WHR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28M | +$80M |
| Q2 2026 | -$214M | -$151M |
| Q1 2026 | -$895M | -$102M |
| Q4 2025 | $989M | +2% |
| Q3 2025 | -$52M | -141% |
| Q2 2025 | -$63M | -123% |
| Q1 2025 | -$793M | +$195M |
| Q4 2024 | $970M | -5.5% |
WHR has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
WHR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.1x | High |
| Q2 2026 | 5.9x | High |
| Q1 2026 | 5.7x | High |
| Q4 2025 | 5.0x | High |
| Q3 2025 | 8.5x | High |
| Q2 2025 | 7.8x | High |
| Q1 2025 | 8.2x | High |
| Q4 2024 | 11.2x | High |
WHR's net debt is about 7.1 years of its operating earnings (EBITDA), down from 8.4 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
WHR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.1 | Neutral |
| Stochastic | 20.7 | Neutral |
WHR's weekly RSI is 32 (neutral) and its Stochastic is 21 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
WHR PE vs Consumer Cyclical Sector
| Metric | WHR | Sector median | Relative |
|---|---|---|---|
| PE | 9.6x | 18x | 47% below |
| PE % | 33 | 47 | 14 pts below |
WHR has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
WHR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.5 | 2.1% below |
| 20 week MA | $35.0 | 17% below |
| 50 week MA | $51.4 | 44% below |
| 100 week MA | $71.2 | 59% below |
| 200 week MA | $95.1 | 70% below |
WHR is in a downtrend: it's below all five of its weekly moving averages, and 70% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
WHR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $145.9 | $193.2 | +32% |
| 2021 | $193.2 | $227.3 | +18% |
| 2022 | $227.3 | $141.6 | -38% |
| 2023 | $141.6 | $121.8 | -14% |
| 2024 | $121.8 | $115.2 | -5.4% |
| 2025 | $115.2 | $72.1 | -37% |
| 2026 YTD | $72.1 | $28.9 | -60% |
WHR has the edge over LCID on returns for 2026, with the stronger performance.